Kayne Anderson Rudnick Investment Management Llc

Source: SEC Form 13F · as of Mar 2026

Kayne Anderson Rudnick Investment Management Llc holds 46 biotech & pharma companies tracked by BioSniper, totaling $609.5M in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$609.5M

CompanySharesValue
WSTWest Pharmaceutical Services Inc.858,298$215.1M
PBHPrestige Consumer Healthcare Inc.2,202,606$130.5M
LLYELI LILLY & Co71,696$65.9M
IDXXIDEXX LABORATORIES INC /DE100,840$56.7M
NRCNational Research Corporation Common Stock (Delaware)2,636,355$44.8M
ABBVAbbVie Inc.111,898$24.3M
JNJJOHNSON & JOHNSON57,103$14.0M
MRKMerck & Co., Inc.67,492$8.1M
MCKMcKesson Corporation9,286$8.0M
REGNREGENERON PHARMACEUTICALS, INC.9,684$7.5M
GILDGILEAD SCIENCES, INC.43,882$6.1M
VRTXVERTEX PHARMACEUTICALS INC / MA13,085$5.8M
AMGNAMGEN INC11,847$4.2M
ABTABBOTT LABORATORIES36,330$3.7M
UNHUnitedHealth Group Incorporated Common Stock (DE)12,213$3.3M
AZNASTRAZENECA PLC14,416$2.8M
INCYIncyte Corp.24,497$2.3M
NVSNovartis AG8,890$1.4M
NVONovo Nordisk A/S30,120$1.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)15,868$876K
ONCBeOne Medicines Ltd.2,279$677K
PMPhilip Morris International Inc3,200$529K
SNYSanofi10,773$519K
CORCencora Inc.1,364$429K
DGXQuest Diagnostics Incorporated1,393$273K
IQVIQVIA Holdings Inc.1,451$248K
PFEPFIZER INC4,164$117K
ZTSZoetis Inc.383$45K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.80$14K
VTRSViatris Inc614$8K
ICLRICON plc58$6K
GMOptec International, Inc.79$6K
GEHCGE HealthCare Technologies Inc.66$5K
BMYBRISTOL MYERS SQUIBB CO66$4K
ELVElevance Health Inc.6$2K
CAHCardinal Health Inc.8$2K
DVADaVita Inc.10$2K
PRGOPERRIGO Co plc129$1K
UTHRUNITED THERAPEUTICS Corp2$1K
ZBHZimmer Biomet Holdings Inc.12$1K
RPRXRoyalty Pharma plc22$1K
ALNYALNYLAM PHARMACEUTICALS, INC.2$662
IONSIONIS PHARMACEUTICALS INC7$526
ICUIICU Medical Inc.3$387
JAZZJazz Pharmaceuticals plc2$378
BIIBBIOGEN INC.0$180

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.